Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
- PMID: 28154374
- DOI: 10.1038/nrc.2016.153
Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
Abstract
Interest in precision diagnostics has been fuelled by the concept that early detection of cancer would benefit patients; that is, if detected early, more tumours should be resectable and treatment more efficacious. Serum contains massive amounts of potentially diagnostic information, and affinity proteomics has risen as an accurate approach to decipher this, to generate actionable information that should result in more precise and evidence-based options to manage cancer. To achieve this, we need to move from single to multiplex biomarkers, a so-called signature, that can provide significantly increased diagnostic accuracy. This Opinion article focuses on the progress being made in identifying protein biomarker signatures of clinical utility, using blood-based proteomics.
Similar articles
-
Recent advances in salivary cancer diagnostics enabled by biosensors and bioelectronics.Biosens Bioelectron. 2016 Jul 15;81:181-197. doi: 10.1016/j.bios.2016.02.040. Epub 2016 Feb 18. Biosens Bioelectron. 2016. PMID: 26946257 Review.
-
Cancer Proteomics and the Elusive Diagnostic Biomarkers.Proteomics. 2019 Nov;19(21-22):e1800445. doi: 10.1002/pmic.201800445. Epub 2019 Aug 7. Proteomics. 2019. PMID: 31172665
-
Circulating tumor DNA as a liquid biopsy _target for detection of pancreatic cancer.World J Gastroenterol. 2016 Oct 14;22(38):8480-8488. doi: 10.3748/wjg.v22.i38.8480. World J Gastroenterol. 2016. PMID: 27784960 Free PMC article. Review.
-
Proteomics in cancer research: Are we ready for clinical practice?Crit Rev Oncol Hematol. 2015 Dec;96(3):437-48. doi: 10.1016/j.critrevonc.2015.07.006. Epub 2015 Aug 12. Crit Rev Oncol Hematol. 2015. PMID: 26277237 Review.
-
Serum proteomics in biomedical research: a systematic review.Appl Biochem Biotechnol. 2013 Jun;170(4):774-86. doi: 10.1007/s12010-013-0238-7. Epub 2013 Apr 23. Appl Biochem Biotechnol. 2013. PMID: 23609910 Review.
Cited by
-
Dual-locked fluorescent probes for precise diagnosis and _targeted treatment of tumors.Heliyon. 2024 Sep 19;10(18):e38174. doi: 10.1016/j.heliyon.2024.e38174. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39381214 Free PMC article. Review.
-
A novel proteomic prognostic signature characterizes the immune landscape and predicts nasopharyngeal carcinoma prognosis.Heliyon. 2024 Sep 18;10(19):e37897. doi: 10.1016/j.heliyon.2024.e37897. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39386833 Free PMC article.
-
Evaluation of a Three-Marker Panel for the Detection of Uveal Melanoma Metastases: A Single-Center Retrospective Analysis.Cancers (Basel). 2021 May 18;13(10):2464. doi: 10.3390/cancers13102464. Cancers (Basel). 2021. PMID: 34070192 Free PMC article.
-
Nanotechnology in cancer diagnosis: progress, challenges and opportunities.J Hematol Oncol. 2019 Dec 17;12(1):137. doi: 10.1186/s13045-019-0833-3. J Hematol Oncol. 2019. PMID: 31847897 Free PMC article. Review.
-
A Metal Chelator as a Plasmonic Signal-Generation Superregulator for Ultrasensitive Colorimetric Bioassays of Disease Biomarkers.Adv Sci (Weinh). 2018 May 21;5(7):1800295. doi: 10.1002/advs.201800295. eCollection 2018 Jul. Adv Sci (Weinh). 2018. PMID: 30027059 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources